Publications by authors named "E Zholdybayeva"

Introduction: Idiopathic pulmonary arterial hypertension (IPAH) is a progressive and fatal disease. The aim of this study was to evaluate the association of polymorphism of the type 2 bone morphogenetic protein receptor gene (BMPR2) with the risk of IPAH development in an ethnic group of Kazakhs. We also describe the clinical and hemodynamic characteristics and outcomes of patients with and without carriers of BMPR2 gene mutations in IPAH.

View Article and Find Full Text PDF

This study explores an adaptation mechanism of to subinhibitory concentrations of meropenem, characterized by an alteration in the production of membrane vesicles (MVs) and modulation of the host inflammatory response. Using a rat model of infection, we demonstrated a significant increase in the size of MVs accompanied by a nonsignificant increase in their number in the meropenem-treated group compared to the infected control. Both infected groups showed significantly altered hematological parameters and shifts in monocyte on day 8 (average increase of 21.

View Article and Find Full Text PDF

Background: The prevalence of isolates resistant to first-line beta-lactam drugs is increasing, resulting in reduced treatment efficacy. Investigating the bacterial transcriptome and proteome can uncover links between bacterial genes and resistance mechanisms. In this study, we experimentally assessed in vitro the transcriptional and proteomic profiles of exposed to SICs of meropenem, an effective antimicrobial agent, collected from patients with intra-abdominal diseases at Astana City Hospital, Kazakhstan.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how genetic variations in certain genes affect the metabolism and effects of the blood thinner dabigatran in patients with atrial fibrillation.
  • Using TaqMan technology, the research analyzed genotypes from 150 patients and found significant differences in dabigatran concentrations based on specific gene polymorphisms.
  • The findings suggest that polymorphisms rs8192935 and rs2244613 influence dabigatran's pharmacodynamics and pharmacokinetics, particularly in the Kazakh population.
View Article and Find Full Text PDF

Type 2 diabetes mellitus (T2DM) is a socially significant disease with increasing prevalence worldwide. It is characterized by heterogeneous metabolic disorders and is associated with various risk factors, including BMI, abnormal lipid levels, hypertension, smoking, dietary preferences, physical inactivity, sedentary lifestyle, family history of diabetes, prediabetes or gestational diabetes, inflammation, intrauterine environment, age, sex, ethnicity, and socioeconomic status. Assessing the genetic risk of developing T2DM in specific populations remains relevant.

View Article and Find Full Text PDF